Octogenarian liver grafts: Is their use for transplant currently justified?

Table 5 Post-liver transplantation complications, retransplant rate and mortality n (%)

Complications and mortality	Donors ≤ 65 yr	Donors ≥ 80 yr	P value
	Group A (n = 102)	Group B (n = 51)
Primary graft non-function	1 (0.98)	1 (1.96)	0.520
Acute rejection	33 (32.4)	10 (19.6)	0.110
Steroid-resistant rejection	6 (5.9)	1 (1.9)	0.200
Chronic rejection	2 (1.9)	1 (1.9)	0.980
Renal dysfunction	17 (16.7)	14 (27.5)	0.150
Renal filtration	1 (0.98)	4 (7.8)
Biliary	16 (15.7)	4 (7.8)	0.380
Vascular	4 (3.9)	0 (0)	0.350
Infections	24 (23.5)	12 (23.5)	0.940
Reoperations	8 (7.8)	4 (7.8)	0.970
HCV recurrence rate	64 (62.7)	34 (66.6)	0.530
Mean period (days from LT)	219 ± 119	251 ± 313	0.830
Retransplant cases	5 (4.9)	2 (3.9)	0.380
Primary non-function	1 (0.98)	1 (1.9)
Chronic rejection	1 (0.98)	0
Biliary complications	2 (1.96)	0
Hepatic artery thrombosis	1 (0.98)	0
HCV recurrence	0	1 (1.9)
Overall mortality	31 (30.4)	15 (29.4)	0.900
Causes of mortality
Cardiovascular	6 (5.9)	7 (13.7)
De novo tumors	8 (7.8)	1 (1.9)
Viral C recurrence	3 (2.9)	3 (5.9)
Infection	3 (2.9)	1 (1.9)
HCC recurrence	3 (2.9)	1 (1.9)
Chronic rejection	3 (2.9)	0 (0)
Primary non-function	1 (0.98)	0 (0)
Other	4 (3.9)	2 (3.9)

HCV: Hepatitis C virus; LT: Liver transplantation;